Journal List > Korean J Adult Nurs > v.28(2) > 1076382

Kim, Cho, and Yoo: Symptom Severity according to the Presence of Depressive and Anxiety Symptoms among Patients with Head and Neck Cancer

Abstract

Purpose

The purpose of this study was to compare symptom severity and the impact of presence of depressive and/or anxiety symptoms among patients with head and neck cancer (HNC).

Methods

One hundred and fifteen patients diagnosed with HNC completed two questionnaires: Hospital Anxiety and Depression Scale (HADS) and the M. D. Anderson Symptom Inventory-Head and Neck Cancer (MDASI-HN).

Results

Of the total sample, 55.6% reported depressive symptoms and 33% reported anxiety symptoms. Patients who reported either depressive or anxiety symptoms also had significantly more severe symptoms. The most severe symptom was dry mouth. Participants who were depressed reported that interference in the enjoyment of life due to symptoms was the most distressing whereas participants with anxiety reported symptom interference in work was of most concern. Of patients reporting moderate to severe symptoms, more than 60% reported depressive symptoms. Of patients reporting moderate to severe feelings of being distress and feeling sad, more than 70% reported anxiety symptoms.

Conclusion

Patients with HNC reporting moderate to severe symptoms also report depressive and/or anxiety symptoms. The results suggest the need to develop an integrated nursing intervention of both physical and emotional symptoms for patients with HNC.

REFERENCES

1.Jemal A., Bray F., Center MM., Ferlay J., Ward E., Forman D. Global cancer statistics. A Cancer of Journal for Clinicians. 2011. 61(2):69–90. http://dx.doi.org/10.3322/caac.20107.
crossref
2.Jung KW., Won YJ., Kong HJ., Oh CM., Cho HS., Lee DH, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Research and Treatment. 2015. 47(2):127–41. http://dx.doi.org/10.4143/crt.2015.060.
crossref
3.National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers version 2.2013 [Internet]. Washington: National Comprehensive Cancer Network;2013. [cited 2013 September 4]. Available from:. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
4.Statistics Korea. Korean Statistical Information Service [Internet]. Seoul: Statistics Korea;2013. [cited 2015 May 27]. Available from:. http://kosis.kr/statHtml/statHtml.do?orgId=117&tblId=DT_11702_N001&vw_cd=&list_id=&scrId=&seqNo=&lang_mode=ko&obj_var_id=&itm_id=&conn_path=E1.
5.Haisfield-Wolfe ME., McGuire DB., Soeken K., Geiger-Brown J., De Forge BR. Prevalence and correlates of depression among patients with head and neck cancer: a systematic review of implications for research. Oncology Nursing Forum. 2009. 36(3):E107–25. http://dx.doi.org/10.1188/09.onf.e107-e125.
crossref
6.Gunn GB., Mendoza TR., Fuller CD., Gning I., Frank SJ., Beadle BM, et al. High symptom burden prior to radiation therapy for head and neck cancer: a patient-reported outcomes study. Head & Neck. 2013. 35(10):1490–8. http://dx.doi.org/10.1002/hed.23181.
crossref
7.Xiao C., Hanlon A., Zhang Q., Ang K., Rosenthal DI., Nguyen-Tan PF, et al. Symptom clusters in patients with head and neck cancer receiving concurrent chemoradiotherapy. Oral Oncology. 2013. 49(4):360–6. http://dx.doi.org/10.1016/j.oraloncology.2012.10.004.
crossref
8.McQuestion M., Fitch M., Howell D. The changed meaning of food: physical, social and emotional loss for patients having received radiation treatment for head and neck cancer. European Journal of Oncology of Nursing. 2011. 15(2):145–51. http://dx.doi.org/10.1016/j.ejon.2010.07.006.
crossref
9.Oskam IM., Verdonck-de Leeuw IM., Aaronson NK., Witte BI., de Bree R., Doornaert P, et al. Prospective evaluation of health-related quality of life in long-term oral and oropharyngeal cancer survivors and the perceived need for supportive care. Oral Oncology. 2013. 49(5):443–8. http://dx.doi.org/10.1016/j.oraloncology.2012.12.005.
crossref
10.Teunissen SC., de Graeff A., Voest EE., de Haes JC. Are anxiety and depressed mood related to physical symptom burden? a study in hospitalized advanced cancer patients. Palliative Medicine. 2007. 21(4):341–6. http://dx.doi.org/10.1177/0269216307079067.
11.Chen ML., Chang HK. Physical symptom profiles of depressed and nondepressed patients with cancer. Palliative Medicine. 2004. 18(8):712–18. http://dx.doi.org/10.1191/0269216304pm950oa.
crossref
12.Gil F., Costa G., Hilker I., Benito L. First anxiety, afterwards depression: psychological distress in cancer patients at diagnosis and after medical treatment. stress and health. 2012. 28:362–7. http://dx.doi.org/10.1002/smi.2445.
crossref
13.Chiou WY., Lee MS., Ho HC., Hung SK., Lin HY., Su YC, et al. Prognosticators and the relationship of depression and quality of life in head and neck cancer. Indian Journal of Cancer. 2013. 50(1):14–20. http://dx.doi.org/10.4103/0019-509X.112279.
14.Rosenthal DI., Mendoza TR., Chambers MS., Asper JA., Gning I., Kies MS, et al. Measuring head and neck cancer symptom burden: the development and validation of the M.D. Anderson symptom inventory, head and neck module. Head & Neck. 2007. 29(10):923–31. http://dx.doi.org/10.1002/hed.20602.
15.Oh SM., Min KJ., Park DB. A study on the standardization of the Hospital Anxiety and Depression Scale for Koreans. Journal Korean Neuropsychiatric Association. 1999. 38(2):289–96.
16.Joseph LA., Routledge JA., Burns MP., Swindell R., Sykes AJ., Slevin NJ, et al. Value of the Hospital Anxiety and Depression Scale in the follow up of head and neck cancer patients. The Journal of Laryngology & Otology. 2013. 127(3):285–94. http://dx.doi.org/10.1017/S0022215113000078.
crossref
17.Krebber AM., Buffart LM., Kleijn G., Riepma IC., de Bree R., Leemans CR, et al. Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psycho-oncology. 2014. 23(2):121–30. http://dx.doi.org/10.1002/pon.3409.
crossref
18.Schag CC., Heinrich RL., Ganz PA. Karn of sky performance status revisited: reliability, validity, and guidelines. Journal of Clinical Oncology. 1984. 2(3):187–93.
19.Lue BH., Huang TS., Chen HJ. Physical distress, emotional status, and quality of life in patients with nasopharyngeal cancer complicated by post-radiotherapy endocrinopathy. International Journal of Radiation Oncology Biology Physics. 2008. 70(1):28–34. http://dx.doi.org/10.1016/j.ijrobp.2007.06.053.
crossref
20.Chen SC., Lai YH., Liao CT., Lin CC., Chang JT. Changes of symptoms and depression in oral cavity cancer patients receiving radiation therapy. Oral Oncology. 2010. 46(7):509–13. http://dx.doi.org/10.1016/j.oraloncology.2010.02.024.
crossref
21.Elting LS. Cooksley CD, Chambers MS, Garden AS. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head and neck malignancies. International Journal Radiation Oncology Biology Physics. 2007. 68(4):1110–20. http://dx.doi.org/10.1016/j.ijrobp.2007.01.053.
22.Keereweer S., Kerrebijn JDF., Al-Mamgani A., Sewnaik A., Baa-tenburg de Jong RJ., van Meerten E. Chemoradiation for advanced hypopharyngeal carcinoma: a retrospective study on efficacy, morbidity and quality of life. European Archives of Otorhinolaryngology. 2012. 269(3):939–46. http://dx.doi.org/10.1007/s00405-011-1694-8.
crossref
23.Maurer J., Hipp M., Schafer C., Kolbl O. Dysphagia impact on quality of life after radio (chemo) therapy of head and neck cancer. Strahlentherapie und Onkologie. 2011. 187(11):744–9. http://dx.doi.org/10.1007/s00066-011-2275-x.
24.So WKW., Chan RJ., Chan DN., Hughes BG., Chair SY., Choi KC, et al. Quality-of-life among head and neck cancer survivors at one year after treatment - a systematic review. European Journal of Cancer. 2012. 48(15):2391–408. http://dx.doi.org/10.1016/j.ejca.2012.04.005.
crossref
25.Karthikeyan G., Jumnani D., Prabhu R., Manoor UK., Supe SS. Prevalence of fatigue among cancer patients receiving various anticancer therapies and its impact on quality of life: a cross-sectional study. Indian Journal of Palliative Care. 2012. 18(3):165–75. http://dx.doi.org/10.4103/0973-1075.105686.
crossref
26.Oh PJ., Jung JA. A meta-analysis of intervention studies on cancer-related fatigue in Korea: 1990-2010. Journal of Korean Clinical Nursing Research. 2011. 17(2):163–75.
27.Reddy SK., Parsons HA., Elsayem A., Palmer JL., Bruera E. Characteristics and correlates of dyspnea in patients with advanced cancer. Journal of Palliative Medicine. 2009. 12(1):29–36. http://dx.doi.org/10.1089/jpm.2008.0158.
crossref
28.Berkey FJ. Managing the adverse effects of radiation therapy. American Family Physician. 2010. 82(4):381–8.
29.Bornbaum CC., Fung K., Franklin JH., Nichols A., Yoo J., Doyle PC. A descriptive analysis of the relationship between quality of life and distress in individuals with head and neck cancer. Support Care Cancer. 2012. 20(9):2157–65. http://dx.doi.org/10.1007/s00520-011-1326-2.
crossref
30.Buchmann L., Conlee J., Hunt J., Agarwal J., White S. Psychosocial distress is prevalent in head and neck cancer patients. Laryngoscope. 2013. 123(6):1424–9. http://dx.doi.org/10.1002/lary.23886.
crossref

Figure 1.
Occurrence of depressive and anxiety symptoms in moderate to severe symptoms.
kjan-28-148f1.tif
Table 1.
Demographic and Disease-related Characteristics of the Participants (N=115)
Characteristics Categories n (%) or M±SD
Age (year)   56.6±11.1
Gender Male 99 (86.1)
Female 16 (13.9)
Spouse Yes 97 (84.4)
No 18 (15.6)
Religion Yes 76 (66.1)
No 39 (33.9)
Education ≤Middle school 26 (22.6)
High school 50 (43.5)
≥College 39 (33.9)
Occupation Disabled due to illness 36 (31.3)
Employed 44 (38.3)
Unemployed 35 (30.4)
Monthly income (10,000 won) ≤150 25 (21.7)
151~350 60 (52.2)
≥351 30 (26.1)
Cancer site Nasopharynx, larynx, 47 (40.8)
pharynx  
Tonsil 26 (22.6)
Oral cavity, tongue, 24 (20.9)
salivary gland  
Nasal cavity, paranasal 14 (12.2)
sinuses  
Other 4 (3.5)
Cancer stage I 11 (9.6)
II 7 (6.1)
III 31 (26.9)
IV 66 (57.4)
Period since diagnosis (month) ≤6 50 (43.5)
7~12 20 (17.4)
13~24 11 (9.6)
25~90 34 (29.5)
Treatment type Operation (Yes) 62 (53.9)
Radiation therapy (Yes) 91 (79.1)
Chemotherapy (Yes) 96 (83.5)
Symptomatic 8 (7.0)
management (Yes)  
Karnofsky performance status (%) 89.3±10.9

Multiple response.

Table 2.
Symptom Severity according to the Presence of Depressive and Anxiety Symptoms (N=115)
Symptom Depressive symptoms p Anxiety symptoms p
Yes (n=64) No (n=51) Yes (n=38) No (n=77)
M±SD M±SD M±SD M±SD
Core items
Pain
Fatigue
3.33±3.04
5.00±2.54
1.78±2.80
2.84±2.28
.006
<.001
4.10±3.31
5.62±2.52
2.03±2.73
3.30±2.40
.002
<.001
Nausea
Disturbed sleep
2.47±2.84
4.13±3.28
1.41±2.10
2.24±2.62
.024
<.001
3.10±3.23
5.05±3.56
1.56±2.15
2.48±2.56
.022
<.001
Feeling of being distressed
Shortness of breath
4.42±3.01
2.37±2.43
1.49±1.85
1.14±1.28
<.001
<.001
5.50±3.13
2.59±2.64
1.99±2.08
1.48±1.81
<.001
.026
Difficulty remembering
Lack of appetite
3.59±2.67
4.46±3.18
1.73±1.96
2.24±2.62
<.001
<.001
3.59±2.56
5.05±3.15
2.32±2.41
2.68±2.82
.008
<.001
Feeling drowsy
Having a dry mouth
3.98±2.65
5.52±3.11
2.98±2.61
3.80±3.04
.044
.004
4.29±2.89
5.83±3.10
3.30±2.59
4.22±3.11
.170
.010
Feeling sad
Vomiting
4.00±3.06
1.33±2.06
1.02±1.66
0.94±2.06
<.001
.319
5.38±2.88
1.71±2.11
1.43±2.03
0.88±1.96
<.001
.042
Numbness or tingling 3.09±2.68 1.76±2.08 .004 3.68±2.78 1.83±2.08 <.001
Head and neck cancer specific items
Problem with oral mucus 2.97±3.31 2.25±3.11 .241 3.39±3.43 2.27±3.06 .073
Difficulty swallowing or chewing
Choking or coughing
4.98±3.76
3.28±2.83
2.67±3.36
1.48±1.95
<.001
<.001
4.79±3.82
3.48±2.88
3.49±3.67
2.08±2.45
.060
.017
Difficulty with voice or speech
Skin pain/burning/rash
4.14±3.57
1.95±2.73
1.88±2.78
0.90±1.43
<.001
.010
4.54±3.89
2.18±2.82
2.44±2.96
1.12±1.88
.005
.035
Constipation
Problem with tasting food
3.02±3.32
4.95±3.40
2.33±2.75
2.98±3.17
.241
.002
3.71±3.45
4.56±3.51
2.27±2.83
3.81±3.42
.029
.225
Mouth/Throat sores
Problem with teeth or gum
3.43±3.30
4.27±3.44
1.59±2.80
2.49±3.09
.002
.005
3.53±3.52
4.52±3.61
2.21±3.00
2.92±3.17
.047
.012
Interference items
General activity
Mood
5.69±3.07
5.36±2.75
2.63±2.73
2.29±2.23
<.001
<.001
6.34±2.82
6.29±2.36
3.35±3.06
2.91±2.60
<.001
<.001
Work
Relations with others
5.89±3.26
5.91±3.18
2.43±2.45
2.51±2.56
<.001
<.001
6.93±2.69
6.64±2.85
3.05±2.93
3.19±2.99
<.001
<.001
Walking ability
Enjoyment of life
4.63±2.99
6.23±2.92
1.96±2.21
2.33±2.26
<.001
<.001
5.43±2.81
6.67±2.56
2.48±2.60
3.38±3.05
<.001
<.001
TOOLS
Similar articles